Add BrightSurf on Google Email

Johns Hopkins Medicine


Johns Hopkins faculty highly value involvement of nearby urban community for improving research

A survey of Johns Hopkins faculty found strong support for working with the local community to make research more relevant and improve its quality. Faculty who conducted community-based research were more likely to hire and collaborate with local residents, and involve them in study design and dissemination.

SourceJohns Hopkins Medicine·JournalJournal of Empirical Research on Human Research Ethics·DateDec 20, 2010

Official food allergy treatment guidelines released

The new guidelines aim to standardize diagnosis, treatment, and management of food allergies. They consolidate the latest available data into straightforward and consistent protocols for diagnosis and treatment, which will give physicians a uniform pool of information, ultimately leading to more accurate care for patients.

SourceJohns Hopkins Medicine·JournalJournal of Allergy and Clinical Immunology·DateDec 9, 2010

Checklist continues to stop bloodstream infections in their tracks, this time in Rhode Island

Researchers in Rhode Island, led by Johns Hopkins Medicine, reduced central-line associated bloodstream infections to near zero using the widely-heralded Johns Hopkins checklist and other patient-safety tools. The intervention prevented 42 infections, saved 10 lives, and reduced ICU stays by 608 days.

SourceJohns Hopkins Medicine·JournalGlobal Journal on Quality and Safety in Healthcare·DateDec 2, 2010

Knowledge gaps, fears common among parents of children with drug-resistant bacteria

A study found that nearly one-fifth of caregivers had never heard of MRSA, highlighting the need for healthcare staff to educate parents about drug-resistant infections. The researchers recommend addressing concerns and allaying fears by providing clear information and risk-minimizing instructions tailored to each child's situation.

SourceJohns Hopkins Medicine·JournalThe Journal of Pediatrics·DateOct 25, 2010

Parkinson's disease: Excess of special protein identified as key to symptoms and possible new target for treatment with widely used anti-cancer drug imatinib

Researchers have discovered that over-activation of the c-Abl protein can shut down parkin's protective function, leading to a build-up of toxic proteins and neuron death. Inhibiting c-Abl with existing drugs like imatinib may provide a new treatment approach for Parkinson's disease.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateOct 1, 2010

Johns Hopkins scientists find genes related to body mass

Researchers at Johns Hopkins University have identified 13 genes associated with human body mass index, shedding light on the complex relationship between epigenetics and obesity. The study, published in Science Translational Medicine, used genome-wide profiling to uncover epigenetic fingerprints that correlate with body weight.

SourceJohns Hopkins Medicine·JournalScience Translational Medicine·DateSep 15, 2010

Keeping stem cells from changing fates

A study published in Cell Stem Cell reveals that NURF, an enzyme that regulates DNA packaging, allows specific genes to be turned on and off in stem cells. This dynamic structure enables stem cells to maintain their potency and prevent differentiation into other cell types.

SourceJohns Hopkins Medicine·JournalCell Stem Cell·DateSep 9, 2010